Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

SPDR S&P Biotech ETF

+ Add to Watchlist

XBI:US

215.4100 USD 5.4800 2.61%

As of 11:35:45 ET on 05/06/2015.

Snapshot for SPDR S&P Biotech ETF (XBI)

Open: 215.3900 High - Low: 216.5000 - 212.0000 Primary Exchange: NYSE Arca
Volume: 734,721 52-Week Range: 119.0000 - 244.9800 Beta vs SPSIBITR: 0.9987

ETF Chart for XBI

No chart data available.
  • XBI:US 215.3750
  • 1D
  • 1M
  • 1Y
209.9300
Interactive XBI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XBI

SPDR S&P Biotech ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to replicate the performance of the S&P Biotechnology Select Industry Index, an equal-weighed index. The Index tracks all the US common stocks listed on the NYSE, American Stock Exchange, NASDAQ National Market and NASDAQ Small Cap exchanges.

Inception Date: 2006-02-06 Telephone: 1-866-787-2257
Managers: JOHN A TUCKER / MICHAEL FEEHILY
Web Site: www.spdrs.com

Fundamentals for XBI

NAV (on 2015-05-05) 209.9300
Assets (M) (on 2015-05-05) 2,204.2650
Shares out (M) 10.50
Market Cap (M) 2,271.40
% Premium 0.00
Average 52-Week % Premium 0.0043
Fund Leveraged N

Dividends for XBI

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2015-03-20) 0.2454
Dividend Yield (ttm) 0.89%

Performance for XBI

1-Month -4.67% 1-Year +62.86%
3-Month +6.39% 3-Year +39.40%
Year To Date +12.71% 5-Year +29.66%
Expense Ratio 0.35

Top Fund Holdings for XBI

Filing Date: 05/05/2015
Name Position Value % of Total
Dyax Corp 1,409,335 34,176,374 1.552%
Esperion Therapeutics Inc 327,846 31,801,062 1.444%
Auspex Pharmaceuticals Inc 308,509 31,159,409 1.415%
Momenta Pharmaceuticals Inc 1,637,495 30,784,906 1.398%
Inovio Pharmaceuticals Inc 3,463,203 28,640,689 1.301%
Amicus Therapeutics Inc 2,635,697 27,094,965 1.231%
Bluebird Bio Inc 203,245 27,043,780 1.228%
Prothena Corp PLC 850,297 26,860,882 1.220%
Ultragenyx Pharmaceutical Inc 426,038 26,682,760 1.212%
Incyte Corp 273,053 26,622,668 1.209%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil